GetTopicDetailResponse(id=3cf38e4696, topicName=HER3抑制劑, introduction=HER3抑制劑, content=null, image=null, comments=0, allHits=630, url=https://h5.medsci.cn/topic?id=8746, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=35194, tagList=[TagDto(tagId=35194, tagName=HER3抑制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2272883, encodeId=b0c622e288375, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a> <a href='/topic/show?id=3cf38e4696' target=_blank style='color:#2F92EE;'>#HER3抑制劑#</a> <a href='/topic/show?id=9b7d8e4574' target=_blank style='color:#2F92EE;'>#HER3#</a>, objectTitle=JCO：HER3的ADC藥物patritumab deruxtecan對(duì)多次治療失敗NSCLC患者，86%肺癌患者腫瘤縮??！, objectType=article, longId=886183, objectId=3ffb88618377, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20250702/fe4cce0f2db645e5bef1dcedf4bd71c0-TK8hr7gAvoD8.jpg, objectUrl=/article/show_article.do?id=3ffb88618377, replyNumber=0, likeNumber=22, createdTime=2025-07-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=3ffb88618377, moduleTitle=JCO：HER3的ADC藥物patritumab deruxtecan對(duì)多次治療失敗NSCLC患者，86%肺癌患者腫瘤縮??！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3ffb88618377)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
